Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.09 - $0.19 $9,291 - $19,615
-103,241 Reduced 77.71%
29,619 $3,000
Q1 2023

May 12, 2023

BUY
$0.15 - $0.83 $19,390 - $107,293
129,269 Added 3599.81%
132,860 $19,000
Q4 2022

Feb 08, 2023

SELL
$0.61 - $175.5 $397 - $114,250
-651 Reduced 15.35%
3,591 $2,000
Q3 2022

Nov 10, 2022

BUY
$1.49 - $145.0 $3,002 - $292,175
2,015 Added 90.48%
4,242 $6,000
Q2 2022

Aug 10, 2022

BUY
$1.4 - $2.4 $3,117 - $5,344
2,227 New
2,227 $4,000
Q1 2022

May 16, 2022

SELL
$1.31 - $4.05 $5,914 - $18,285
-4,515 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$3.49 - $5.58 $15,757 - $25,193
4,515 New
4,515 $18,000

About Tivic Health Systems, Inc.


  • Ticker TIVC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,677,730
  • Market Cap $2.52M
  • Description
  • Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own w...
More about TIVC
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.